Tucker et al v. Wright Medical Technology, Inc. et al
Filing
33
ORDER DENYING Transfer of Action to MDL-2329. Signed by MDL Panel Chairman. (kc, COURT STAFF) (Filed on 2/9/2012)
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 1 of 6
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION
IN RE: WRIGHT MEDICAL TECHNOLOGY, INC., CONSERVE
HIP IMPLANT PRODUCTS LIABILITY LITIGATION
MDL No. 2329
TRANSFER ORDER
Before the Panel:* Pursuant to 28 U.S.C. § 1407, plaintiff in a Southern District of Georgia
action (James) moves for centralized pretrial proceedings in the Northern District of Georgia.
Plaintiff’s motion encompasses five actions pending in five districts, as listed on Schedules A and B.
The cases in this litigation primarily involve alleged defects in Wright’s Conserve line of hip implant
products.1 Most plaintiffs’ claims focus upon the metal-on-metal design of the Conserve products
and the alleged propensity of the devices to generate high levels of metal debris, cause metallosis in
the surrounding tissue and/or fail early (including loosening of the acetabular cup). The Panel has
been notified of seventeen additional, potentially related actions pending in nine districts.2
I.
Defendants3 oppose centralization and, alternatively, support selection of the Northern District
of Georgia as the transferee district. Plaintiffs in three potential tag-along actions pending,
respectively, in Arizona, Colorado and Oregon also oppose centralization but only to the extent that
it will delay the progress of their respective actions; these plaintiffs suggest centralization in the
District of Arizona. Plaintiffs in the Northern District of California Tucker action oppose
centralization of their action. Responding plaintiffs in the District of Utah Snitkoff action and six
potential tag-along actions primarily support centralization in the Northern District of Georgia.
*
Judges W. Royal Furgeson, Jr., and Marjorie O. Rendell did not participate in the decision
of this matter.
1
Conserve Femoral Surface Replacement; Conserve Plus Total Resurfacing Hip System;
Conserve Total A-Class Advanced Metal; and Conserve Total Hip System.
2
These actions and any other related actions are potential tag-along actions. See Rules 1.1(h),
7.1 and 7.2, R.P.J.P.M.L.
3
Wright Medical Group, Inc., and Wright Medical Technology, Inc. (collectively Wright).
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 2 of 6
-2Certain plaintiffs suggest the Central District of California or the Southern District of Georgia as
alternative transferee districts.
Wright sets out a number of reasons for opposing centralization. First, it says that the multiple
intervening causation issues – such as a given plaintiff’s health, medical issues and lifestyle – are
prominent in all actions. Therefore, Wright asserts, the actions are actually dissimilar. However,
almost all injury litigation involves questions of causation that are case- and plaintiff-specific. Such
differences have not been an impediment to centralization in the past. See, e.g., In re Zimmer Durom
Hip Cup Prods. Liab. Litig., 717 F.Supp.2d 1376, 1378 (J.P.M.L. 2010).4 Wright also suggests that
certain of plaintiffs’ contentions regarding the Conserve device are wholly without merit. As the
Panel held long ago, “[t]he framers of Section 1407 did not contemplate that the Panel would decide
the merits of the actions before it and neither the statute nor the implementing Rules of the Panel are
drafted to allow for such determinations.” In re: Kauffman Mutual Fund Actions, 337 F.Supp. 1337,
1339-40 (J.P.M.L. 1972). Wright also strongly questions moving plaintiff’s motives for seeking
centralization. In short, Wright’s arguments are not convincing to us in these circumstances. Wright
can seek dismissal or other relief from the transferee judge, who will be intimately familiar with the
nuances of this litigation.
For all these reasons, on the basis of the papers filed and the hearing session held, we find that
these actions involve common questions of fact, and that centralization will serve the convenience of
the parties and witnesses and promote the just and efficient conduct of the litigation. The actions
share factual questions concerning design, manufacture, marketing and performance of Wright’s
Conserve line of hip implant products. Centralization will eliminate duplicative discovery, prevent
inconsistent pretrial rulings on discovery and other issues, and conserve the resources of the parties,
their counsel and the judiciary.
II.
A few other matters on individual cases require our attention.
Plaintiffs in the Northern District of California Tucker action oppose centralization of their
action on the grounds that plaintiff did not receive a Conserve device. Wright agrees, as does moving
4
“In opposing centralization, Zimmer argues, inter alia, that the actions involve multiple
individualized fact issues (for example, with respect to causation), and that creation of an MDL might
derail its ongoing efforts to settle claims involving the Durom Cup quickly and without the
expenditure of substantial time and resources. We understand these arguments, but our experience
causes us to respectfully disagree as to their significance. Though the actions certainly present some
individual issues, this is usually true of device cases and other products liability cases.”
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 3 of 6
-3plaintiff, who acknowledges having mistakenly included Tucker on the motion for centralization.
Given the agreement of the parties, we decline to centralize this unrelated action.
Relatedly, it is unclear whether plaintiff in the District of Arizona Welch action includes
allegations regarding a Conserve device or whether the action is exclusively focused on non-Conserve
components of her hip implant. Given the possibility that plaintiff in Welch is making some claims
regarding a Conserve hip implant, we are unwilling, based on the record before us, to conclude that
Welch warrants exclusion from the centralized proceedings. Instead, we encourage the transferee
judge to scrutinize whether plaintiff alleges defects associated with a Conserve device. If the
transferee judge discovers that a Conserve hip implant is, in fact, not at issue in Welch (or any other
transferred action), then we encourage him to promptly suggest that the Panel remand such action
to the transferor court. See Rule 10.1(b), R.P.J.P.M.L.; In re ClassicStar Mare Lease Litig., 528
F.Supp.2d 1345, 1347 (J.P.M.L. 2007).
The concerns of plaintiffs in three potential tag-along actions that centralization may slow the
progress of their respective action are best addressed by opposing the conditional transfer order
covering the actions, if issued, or by presenting such arguments to the transferee judge.
III.
Finally, we conclude that the Northern District of Georgia is an appropriate transferee district
for centralized pretrial proceedings in this litigation. These cases involve medical devices that are
marketed and sold throughout the nation. Wright is based in Arlington, Tennessee, and most parties
agree that N.D. Georgia would be an appropriate transferee forum. The district is geographically
central, accessible, and enjoys favorable docket conditions. Further, Judge William S. Duffey, Jr.,
is an experienced transferee judge who we are confident will steer this litigation on a prudent course.
IT IS THEREFORE ORDERED that, pursuant to 28 U.S.C. § 1407, the actions listed on
Schedule A are transferred to the Northern District of Georgia and, with the consent of that court,
assigned to the Honorable William S. Duffey, Jr., for coordinated or consolidated pretrial
proceedings.
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 4 of 6
-4IT IS FURTHER ORDERED that transfer of the action listed on Schedule B is denied.
PANEL ON MULTIDISTRICT LITIGATION
_________________________________________
John G. Heyburn II
Chairman
Kathryn H. Vratil
Paul J. Barbadoro
Barbara S. Jones
Charles R. Breyer
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 5 of 6
IN RE: WRIGHT MEDICAL TECHNOLOGY, INC., CONSERVE
HIP IMPLANT PRODUCTS LIABILITY LITIGATION
MDL No. 2329
SCHEDULE A
District of Arizona
Virginia M. Welch v. Wright Medical Technology Inc., et al., C.A. No. 2:11-002113
Central District of California
Carole Kearn v. Wright Medical Group, Inc., et al., C.A. No. 5:11-01652
Southern District of Georgia
Danny L. James, Sr. v. Wright Medical Technology, Inc., et al., C.A. No. 2:11-00200
District of Utah
Eric B. Snitkoff v. Wright Medical Technology, Inc., et al., C.A. No. 2:11-00390
Case MDL No. 2329 Document 67 Filed 02/08/12 Page 6 of 6
IN RE: WRIGHT MEDICAL TECHNOLOGY, INC., CONSERVE
HIP IMPLANT PRODUCTS LIABILITY LITIGATION
SCHEDULE B
Northern District of California
Gregory K. Tucker, et al. v. Wright Medical Technology, Inc., et al.,
C.A. No. 4:11-03086
MDL No. 2329
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?